期刊文献+

前列腺特异性抗原前体及其相关参数在前列腺癌诊断中的研究进展 被引量:7

Pro-prostate-specific antigen and its related indexes in the diagnosis of prostate cancer
下载PDF
导出
摘要 前列腺特异性抗原前体(pro PSA)是前列腺特异性抗原(PSA)的前体蛋白,是游离PSA(f PSA)的一种形式。近年来,人们对pro PSA及其相关参数在前列腺癌(PCa)诊断中的意义及其临床应用价值进行了大量的研究,并取得了很大进展。pro PSA相关参数包括pro PSA百分比(%p PSA)、p2PSA、%p2PSA、前列腺健康指数(PHI)等,这些指标在PCa诊断中的作用明显优于血清总PSA(t PSA)和f PSA,特别是%p2PSA和PHI可以显著提高对PCa的检测和鉴别能力,降低不必要的穿刺活检率。本文就pro PSA及其相关检测指标在PCa诊断中应用的研究进展作一综述。。 Pro-prostate-specific antigen( pro PSA) is the precursor of PSA and a form of free PSA( f PSA). In recent years,a lot of studies have been done on pro PSA,the roles of its related indexes in the diagnosis of prostate cancer,and the value of its clinical application. The correlated indexes of pro PSA include pro PSA,% p PSA,p2 PSA,% p2 PSA and prostate health index( PHI). They are more effective than total PSA( t PSA) and f PSA in the diagnosis of prostate cancer,especially % p2 PSA and PHI,which may significantly increase our ability to detect and identify PCa and lower the rate of unnecessary biopsies. This article presents an overview on the advances in the studies of pro PSA and the application of its related indexes in the diagnosis of prostate cancer.
作者 姜亮 卢一平
出处 《中华男科学杂志》 CAS CSCD 北大核心 2015年第7期655-658,共4页 National Journal of Andrology
关键词 前列腺特异性抗原前体 前列腺特异性抗原前体百分比 前列腺健康指数 前列腺癌 诊断 pro-prostate-specific antigen % p PSA prostate health index prostate cancer diagnosis
  • 相关文献

参考文献25

  • 1Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin, 2014, 64(1) : 9-29.
  • 2Stokes ME, Black L, Benedict A, et al. Long-term medical-care costs related to prostate cancer: Estimates from linked SEER- Medicare data. Prostate Cancer Prostatic Dis, 2010, 13 (3) : 278 -284.
  • 3Stephan C. Prostate cancer: WHO standardization of PSA tests: Clinical consequences. Nat Rev Urol, 2009, 6(6) : 303-305.
  • 4Mikolajczyk SD, Catalona WJ, Evans CL, et al. Proenzyme forms of prostate-specific antigen in serum improves the detection of pros- tate cancer. Clin Chem, 2004, 50(6) : 1017-1025.
  • 5Raaijmakers R, Wildhagen MF, 1to K, et al, Prostate-specific antigen change in the European randomized study of screening for prostate cancer. Urology, 2004, 63 (2) : 316-320.
  • 6Bangma CH, Wildhagen MF, Yurdakul G, et al. The value of (- 7, -5 ) pro-prostale-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer. BJU Int, 2004, 93 (6) : 720-724.
  • 7Niemela P, Lovgren J, Karp M, et al. Sensitive and specific en- zymatic as say for the determination of precursor forms of prostate- specific antigen after an activation step. Clin Chem, 2002, 48 (8) : 1257-1264.
  • 8Balk SP, Ko YJ, Buhley GJ. Biology of prostate-specific anti- gen. J Clin Oncol, 2003, 21(2): 383-391.
  • 9Mikolajezyk SD, Rittenhouse HG. ProPSA: A more cancer-spe- cific form of prostate specific-antigen for the early detection of prostate cancer. Keio J Med, 2003, 52(2) : 86-91.
  • 10潘铁军,刘波,沈国球,文瀚东,涂忠,郭骏,杨家荣.F-PSA/T-PSA比值提高灰区前列腺癌活检阳性率的研究[J].中华男科学杂志,2010,16(2):170-171. 被引量:9

二级参考文献6

共引文献8

同被引文献51

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部